France
National Health Strategy 2018-2022
Documents
-
- Promote biosimilar medicines that have the same efficacy, quality and safety as the reference biological medicine, with the objective of reaching 80% penetration of biosimilars in their reference market by 2022.
-
1 prescription in the directory for every 2 prescriptions
-
Reduce antibiotics consumption by 25% by 2020